| 证券代码 | AKRX.O |
| 证券名称 | 爱克龙药业 |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2007-02-07 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Akorn, Inc. |
| 注册地址 | 美国路易斯安那州 |
| 办公地址 | 1925 W. Field Court, Suite 300, Lake Forest, Illinois, USA |
| 成立日期 | 1971 |
| 董事会主席 | Alan Weinstein |
| 公司属地 | United States 美国 |
| 公司网址 | www.akorn.com |
| 电话 | +1 (847) 279-6100 |
| 传真 | - |
| 公司简介 | Akorn, Inc., together with its wholly-owned subsidiaries is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. They are an industry leader in the development, manufacturing and marketing of specialized generic pharmaceutical products in alternative dosage forms. They focus on difficult-to-manufacture sterile and non-sterile dosage forms including, but not limited to, ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. |